Ligand Sells Screening Technology
socalTECH
OCTOBER 7, 2010
San Diego-based Ligand Pharmaceuticals announced today that it has agreed to sell its combinatorial compound library and screening technology, in a deal worth $1.8M. According to Ligand, it is selling the technology to Venenum Biodesign, LLC.,
Let's personalize your content